Moroccan government drops $500M into new Recipharm fill-finish plant in big boost for African manufacturing
Recipharm has inked a deal with the Moroccan government to build a new fill-finish factory over the next five years to up vaccine and therapeutic capacity and capability, the company announced Tuesday.
The Moroccan government will invest $500 million in the build, which will be primary dedicated to African vaccine manufacture.
The factory will be operational by 2023, if all goes according to plan, and will mirror the company’s current fill-finish site in Monts, France; except at 107,000 square feet, it will be operating on a much larger scale. Recipharm will not be on the hook for any of the money going into the plant, just its operations, a spokesperson for the company confirmed in an email to Endpoints News on Thursday.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 113,500+ biopharma pros reading Endpoints daily — and it's free.